|
|
|
|
|
Detail |
hsa-miR-335 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
Distinctive patterns of microRNA expression in primary muscular disorders. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia. |
2007 |
|
|
|
|
|
|
hsa-miR-335 |
|
Causal |
Endogenous human microRNAs that suppress breast cancer metastasis. |
2008 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
MicroRNA expression and identification of putative miRNA targets in ovarian cancer. |
2008 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. |
2008 |
|
|
|
|
|
|
hsa-miR-335 |
|
Unspecified |
An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma. |
2008 |
|
|
|
|
|
|